Sunrest Lifescience Limited

About the company

## **About  Sunrest Lifescience Limited** Incorporated in 2017, “Sunrest Lifescience Private Limited  is engaged in the marketing of OTC generic pharmaceutical products in the domestic market. The company offers a  range of pharmaceutical products manufactured by third party manufacturers. They operate in different States of India such as Maharashtra, Gujarat, Madhya Pradesh, Orissa and Rajasthan. They  have presence in these States through Trade Mark registered products and/or products under registration. They  deal in Capsules, Tablets, Syrup, Ointment, Gel, Mouth Wash, Solution, Suspension, Dry Powders and Toothpaste. Our product portfolio comprises of vide range of drugs like Anti-Bacterial, Anti Diarrheal, AntiFungal, Anti Malerial, Anti Diabetic, Dental Cure, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Cosmetic, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical and Anti-inflammatory. The company has 18 Registered Trademarks for 32 products. The products of the Company are sold to Stockists and Super Stockists & in turn it is available at Chemist shops, Dispensaries, Hospitals etc. Sunrest Lifescience Private Limited is set to debut its initial public offering (IPO). The proceeds generated from the Fresh Issue will be allocated towards the following objectives 1. Working capital requirements. 1. General Corporate purposes. Here are key details about the Sunrest Lifescience Limited IPO: Company Name| **Sunrest Lifescience Limited Limited**|  | Sunrest Lifescience Limited IPO Opening Date| **7 November 2023** ---|---|---|---|--- Company Established On|**2017**Sunrest Lifescience Limited IPO Price band|**₹ 84 per share**

Financial performance (₹ Cr)

IPO Roadmap / Timeline

1. IPO Opens

   Completed
   07 Nov 2023

   Bidding starts for all investor categories

2. IPO Closes

   Completed
   09 Nov 2023

   Last day to place your bid

3. Basis of Allotment

   Completed
   09 Nov 2023

   Share allotment finalised

4. Refund Initiation

   Completed
   16 Nov 2023

   Refunds credited for non-allottees

5. Credit to Demat

   Completed
   15 Nov 2023

   Allotted shares credited to demat account

6. Listing on Exchange

   Completed
   20 Nov 2023

   Shares list on NSE / BSE

Post-close dates are indicative as per SEBI T+3 listing framework and may change per registrar updates.